Author

Shéhérazade Sebda

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Approach:transformer / foundation model· 1

Frequent Co-Authors

Jean‐Pascal MenebooiD· 2 shared Martin FigeaciD· 2 shared Anamika Pandey· 1 shared Audrey Lasne‐CardoniD· 1 shared Céline BazilleiD· 1 shared Céline VillenetiD· 1 shared Corinne Jeanne· 1 shared David TulasneiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jean‐Pascal MenebooORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMar 24, 2026

Predicting Head and Neck Squamous Cell Carcinoma outcomes using long-term Patient-Derived Tumor Organoids

Marion Perréard, Jordane Divoux, Félicie Perrin…·Louis‐Bastien Weiswald

This study uses patient-derived tumor organoids to predict HNSCC patient outcomes, finding strong associations between organoid responses to cisplatin and X-rays and clinical prognosis.

DOI 10.64898/2026.03.22.713356

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyCell Death and DiseasePeer-reviewedNov 3, 2025

Transcriptional program-based deciphering of the MET exon 14 skipping regulation network

Marie‐José Truong, Geoffrey Pawlak, Jean‐Pascal Meneboo…·David Tulasne

The paper identifies a regulatory network involving ETS1, FOSL1, and SMAD3 that mediates MET exon 14 skipping in lung cancer, showing their role in RAS-ERK pathway activation and potential as therapeutic targets.

3 citations

humanbulk RNA-seq

𝕏 PostBluesky